Synthesis and Evaluation of the Cytotoxicity of a Series of ۱,۳,۴-Thiadiazole Based Compounds as Anticancer Agents
محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 16، شماره: 11
سال انتشار: 1392
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 170
فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-16-11_002
تاریخ نمایه سازی: 4 آبان 1400
چکیده مقاله:
Objective(s): Nowadays, cancer is an important public health problem in all countries. Limitations of current chemotherapy for neoplastic diseases such as severe adverse reactions and tumor resistance to the chemotherapeutic drugs have been led to a temptation for focusing on the discovery and development of new compounds with potential anticancer activity. Materials and Methods: A new series of ۱,۳,۴-thiadiazole-derived compounds (۳a-۳l) were synthesized. N-(۵-Mercapto-۱,۳,۴-thiadiazol-۲-yl)-۲-(۴-methoxyphenyl) acetamide (۲) was prepared through direct amidation of ۴-methoxyphenylacetic acid (۲) with ۵-amino-۱,۳,۴-thiadiazole-۲-thiol using EDC (N-Ethyl-N-dimethylaminopropyl carbodiimide) and HOBt (Hydroxybenzotriazole). Then, various derivatives of benzyl chloride containing electron withdrawing and electron donating moieties were reacted with compound ۲ to prepare compounds ۳a-۳l. In vitro cytotoxicity assessment using MTT method was applied and results are presented as IC۵۰. Results: All the synthesized compounds were characterized by ۱H-NMR and IR spectroscopy. Some of the synthesized compounds were also characterized using MS spectroscopy. Related melting points were also recorded. According to the obtained data from MTT assay, all compounds (۳a-۳l) demonstrated a higher cytotoxic activity against MDA-MB-۲۳۱ breast cancer cell line in comparison with other cell lines. Conclusion: It is notable that four synthesized compounds ۳h (IC۵۰= ۱۱ ± ۰.۱۸ μM), ۳j (IC۵۰= ۱۰ ± ۰.۳۹ μM), ۳k (IC۵۰= ۱۱ ± ۰.۷۷ μM) and ۳l (IC۵۰= ۸ ± ۰.۶۹ μM) exhibited higher cytotoxic activity against MDA-MB-۲۳۱ cell line compared to imatinib (IC۵۰= ۲۰ ± ۰.۶۹ μM) as the reference drug.
کلیدواژه ها:
نویسندگان
Alireza Aliabadi
Department of Medicinal Chemistry, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
Elham Eghbalian
Department of Medicinal Chemistry, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran ۲ Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
Amir Kiani
Department of Pharmacology, Toxicology and Medical Services, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :